Brentuximab vedotin: Difference between revisions
From IDWiki
(Created page with "* Monoclonal antibody that targets CD30 linked with a cytotoxic drug * Indicated for Hodgkin lymphoma, anaplastic large cell lymphoma, and T-cell lymphoma * Has been linked to PML and now has a black box warning for this Category:Monoclonal antibodies Category:Oncology") |
No edit summary |
||
| Line 2: | Line 2: | ||
* Indicated for [[Hodgkin lymphoma]], [[anaplastic large cell lymphoma]], and [[T-cell lymphoma]] |
* Indicated for [[Hodgkin lymphoma]], [[anaplastic large cell lymphoma]], and [[T-cell lymphoma]] |
||
* Has been linked to [[PML]] and now has a black box warning for this |
* Has been linked to [[PML]] and now has a black box warning for this |
||
| + | * Also concern for [[CMV]] and [[HBV]] reaction and [[Pneumocystis]] pneumonia |
||
| + | * Monitor for CMV, but no routine prophylaxis is usually offered |
||
[[Category:Monoclonal antibodies]] |
[[Category:Monoclonal antibodies]] |
||
Latest revision as of 14:52, 24 November 2023
- Monoclonal antibody that targets CD30 linked with a cytotoxic drug
- Indicated for Hodgkin lymphoma, anaplastic large cell lymphoma, and T-cell lymphoma
- Has been linked to PML and now has a black box warning for this
- Also concern for CMV and HBV reaction and Pneumocystis pneumonia
- Monitor for CMV, but no routine prophylaxis is usually offered
